Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Verastem (VSTM) Return on Sales: 2018-2025

Historic Return on Sales for Verastem (VSTM) over the last 7 years, with Sep 2025 value amounting to -16.34%.

  • Verastem's Return on Sales fell 3918.00% to -16.34% in Q3 2025 from the same period last year, while for Sep 2025 it was -16.34%, marking a year-over-year decrease of 3918.00%. This contributed to the annual value of -13.07% for FY2024, which is 3417.00% down from last year.
  • Verastem's Return on Sales amounted to -16.34% in Q3 2025, which was down 128.28% from 57.77% recorded in Q2 2025.
  • Over the past 5 years, Verastem's Return on Sales peaked at 57.77% during Q2 2025, and registered a low of -60.15% during Q4 2022.
  • Over the past 3 years, Verastem's median Return on Sales value was 24.08% (recorded in 2024), while the average stood at 25.04%.
  • Its Return on Sales has fluctuated over the past 5 years, first surged by 5,964bps in 2023, then crashed by 3,918bps in 2025.
  • Over the past 5 years, Verastem's Return on Sales (Quarterly) stood at -34.68% in 2021, then slumped by 2,546bps to -60.15% in 2022, then surged by 4,987bps to 20.42% in 2023, then skyrocketed by 242bps to 25.33% in 2024, then plummeted by 3,918bps to -16.34% in 2025.
  • Its last three reported values are -16.34% in Q3 2025, 57.77% for Q2 2025, and 36.19% during Q1 2025.